Search

everythinglearnresearchcommunity

for

Search:↓

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

Hair loss drugs may cause sexual issues and infertility in men.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5-ARI therapy may help prevent prostate cancer progression.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Finasteride and dutasteride can affect sexual function in BPH patients.

The method effectively measures drug impact on DHT levels in prostate treatments.

Finasteride effectively reduced priapism episodes in children with sickle cell disease without side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

Certain Dibenzo derivatives may help treat prostate cancer.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Finasteride may help treat BPH by affecting certain biological markers.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.